1. Biopharma ramps up lobbying spend as drug pricing legislation nears — Roche culls two COVID-19 hopefuls amid Q1 clear-out — FDA offers scathing review of Emergent plantSee more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Edit Tags: Congratulatuons!!!! Aerie listed #1

Multiple tags may be separated by commas.